EXCLUSIVE

Home visits = regulatory thumbs up? ResearchNurses.co thinks so

By Natalie Morrison

- Last updated on GMT

Related tags: Patient

Regulatory approval: home visits boost chances
The use of home visits in clinical trials could raise the chances of regulatory approval, according to ResearchNurses.co.

In the second part of an exclusive podcast with Outsourcing-Pharma (listen to yesterday’s podcast here​) Sue Mackay said that the levels of compliance offered by having a healthcare professional give drugs to patients who would otherwise self-administer is a big plus for the authorities.

“The dosage will be correct,”​ the research nursing team manager said. “So from a regulatory perspective – I think they would probably quite like that.”

She added that for data collection and monitoring, home visits are a way to boost accuracy.

Mackay also said that the regulators are currently putting an increasing focus on patient retention, something she believes home visits can help with because it is more “flexible” ​for the patient, and provides them with a personalised point of contact.

“It’s becoming a bigger issue for companies to try to maintain levels of recruitment in studies,”​ she said.

“I think the regulatory bodies both in the states and here in the UK and Europe and Asia, are looking at is ‘what would make a patient want to be in this study, and stay in this study?’”

Related news

Show more

Related products

show more

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Empowering Clinical Trial Sponsors with Analytics

Empowering Clinical Trial Sponsors with Analytics

PerkinElmer | 14-Jul-2021 | Technical / White Paper

Is your Clinical Data Review creating problems or solving them? Take Control of Your Data. PerkinElmer Informatics Clinical Solutions, powered by Tibco...

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

Related suppliers

Follow us

Products

View more

Webinars